Khosla Ventures Overview
Khosla Ventures provides venture assistance and strategic advice to entrepreneurs working on breakthrough technologies. The firm was founded in 2004 by Vinod Khosla, co-founder of Sun Microsystems. With over five billion dollars under management, the firm focuses on a broad range of areas including consumer, enterprise, education, advertising, financial services, semiconductors, health, big data, agriculture/food, sustainable energy and robotics. Khosla Ventures is headquartered in Menlo Park, California.
Latest News
growth-positive
VC firms are pioneering a new investment strategy: acquiring established businesses and optimizing them with AI to boost efficiency and customer reach.
Venture capital firms, including Khosla Ventures, are exploring a new investment strategy that involves acquiring mature businesses and optimizing them with artificial intelligence. This approach, similar to private equity roll-ups, aims to enhance service delivery through automation. General Catalyst has already invested in several companies, including Long Lake, which has raised $670 million. Khosla Ventures is cautiously considering this strategy, recognizing the potential benefits for AI startups in accessing established clients. The firm plans to partner with a PE-style firm for acquisitions if initial investments prove successful. This strategy could provide AI startups with immediate access to large customer bases, addressing challenges in securing clients.
InvestmentAcquisitionPartners
Khosla Ventures aims to raise about $3.5 billion for its next seed, venture and growth funds
growth-positive
WSJ News Exclusive | Khosla Ventures Closes In on $3 Billion for Venture Funds, Defying Startup Slump
Khosla Ventures is nearing the completion of a $3 billion fundraising round for its latest set of venture funds. This comes despite a slowdown in growth and lower valuations for startups. The fundraising round will be one of the largest completed by a venture firm in 2023 and marks an increase from the $1.85 billion Khosla Ventures raised three years prior.
Investment
growth-positive
Drug discovery startup Valo goes public via SPAC merger with Khosla Ventures
Valo Health, a tech-enabled drug discovery company, announced plans to go public through a $2.8 billion SPAC deal with Khosla Ventures Acquisition Co. The deal is expected to close in the third quarter of this year and will include $168.5 million in PIPE funding from investors such as Khosla Ventures, NG MGG Strategic, and Caz Investments. Valos Opal Computational Platform, which uses AI and human-centric data for drug discovery, aims to accelerate development processes. The company hopes to become the industry-standard platform for drug discovery by scaling and democratizing its technology. This move aligns with the trend of SPAC mergers in digital health.
Public TradingPIPEPartners
growth-positive
Khosla Ventures targets $1.1bn Private Equity International
The article is about registering for limited access to industry news, analysis, and data, along with regular email updates.
Team Members
17
Web & Social Links
| Website | www.khoslaventures.com |
Locations
2128 Sand Hill Road, Menlo Park, CA, USA
Photos & Videos
No files yet
